Oxford BioMedica and Axovant Worldwide Exclusive Licence Agreement for OXB-102 for Parkinson’s disease
This document is hosted externally.
Unless the owner has removed it from the web, you can access the full document via its original URL:
https://www.oxb.com/system/files/corporate-presentations/180606%20Axovant%20Agreement%20Analyst%20Presentation%20_Final.pdfUnless the owner has removed it from the web, you can access the full document via its original URL:
See similar contracts (1)
Alternatively, you can try searching for similar contracts: